A blog reader (thanks!) gave me the link to this not-so-shocking-anymore (!) article about Omniscan, a gadolinium-based contrast agent that often gets injected into the veins of patients undergoing MRIs, including myeloma patients: http://goo.gl/scjaG. (I decided to post the link today because it’s veeeeeeery closely related to the post I published two days ago on “evidence-based medicine.”)
Do you remember my posts on gadolinium? If not, just click here: http://goo.gl/VeqeB
In a nutshell, gadolinium is a toxic metal that makes myeloma cells proliferate like crazy. And now it appears that “unfavorable data” regarding Omniscan was supposed to have been burned in 1994 (!). Luckily, it wasn’t, thanks to the researcher who “reached troubling findings”…Don’t miss the part about the 25% of missing gadolinium…eeeek.
Well, as I mentioned in my previous, related post, in my opinion…
WE NEED TO KNOW ABOUT THIS STUFF.
UPDATE: thanks to a query by a member of the Italian MGUS support group on Facebook (of which I am co-administrator), I found this abstract, titled “Nephrogenic systemic fibrosis: the first Italian gadolinium-proven case” http://goo.gl/qTwvH Eeeek.